We have previously shown that DeMeth insulin cfDNA levels are increased during the natural progression of T1D in the NOD mouse and are reduced following the development of hyperglycemia, demonstrating the utility of DeMeth insulin DNA as a biomarker of insulin-expressing β-cell death in prediabetes [8]. The gene discussed is INS; the disease is type 1 diabetes mellitus.